🇺🇸 FDA
Patent

US 7256212

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

granted A61KA61K9/282A61K9/5021

Quick answer

US patent 7256212 (Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K9/282, A61K9/5021, A61P, A61P3/06